Date of announcement  2019/08/26
Time of announcement  17:15:36
 
Date of events   2019/08/26 
To which item it meets paragraph 21
Statement 
1.Date of the shareholders' meeting resolution:2019/08/26
2.Name and title of the director with permission to engage in competitive
  conduct:
(1)Shin Chen / Director
(2)Lionel de Saint-Exupery / Director
(3)Chun-Huei Ho / Director
(4)Yi-Chun Nan / Director
(5)Shaio-Tung Chang / Director
(6)Paul Yang / Director
(7)Tyzz - Jiun Duh / Independent Director
(8)Yih Jeng / Independent Director
3.Items of competitive conduct in which the director is permitted to engage:
Engaged in business of other companies that are within
or similar to the business scope of the Company.
4.Period of permission to engage in the competitive conduct:Appointment term.
5.Circumstances of the resolution (please describe the results of the voting
  under Article 209 of the Company Act):
Approved by the board of directors without the
attendance of the interested directors.
6.If the permitted competitive conduct is business of a mainland China area
  enterprise, the name and title of the director (if it is not business of a
  mainland China area enterprise, please enter ”not applicable” below):
(1)Shin Chen / Director
(2)Paul Yang / Director
7.Company name of the mainland China area enterprise and the director's
  position in the enterprise:
(1)Shin Chen: CDIB Private Equity (Fujian) Co. Ltd. /
Chairman; CDIB Yida Private Equity (Kunshan) Co. Ltd. / Chairman
(2)Paul Yang: KKR Asia Limited / Partner & CEO of Greater
China; SinoCare Group Holdings Limited / Legal Representative
and Executive Director
8.Address of the mainland China area enterprise:
(1)CDIB Private Equity (Fujian) Co. Ltd.:
Room 02, 35F, Hengli Building, No. 128-1, Wusi Road,
Fuzhou City, Fujian
(2)CDIB Yida Private Equity (Kunshan) Co. Ltd.:
Room 1201, No. 1228, Qianjin East Road, Kunshan City, Jiangsu
(3)KKR Asia Limited: 41F, China World Tower 3, No.1
Jianguomenwai Street, Chaoyang District, Beijing
(4)SinoCare Group Holdings Limited: Room 201, Building A,
No. 1 Qianwan 1st Road, Qianhai Shenzhen-Hong Kong
Cooperation Zone, Shenzhen
9.Business items of the mainland China area enterprise:
(1)CDIB Private Equity (Fujian) Co. Ltd.: Trustee
management for non-securities investment and
relevant equity investment advisory services.
(2)CDIB Yida Private Equity (Kunshan) Co. Ltd.:
Trustee management for non-securities investment
and relevant equity investment advisory services.
(3)KKR Asia Limited: Financial services.
(4)SinoCare Group Holdings Limited: Investment
in medical industry.
10.Degree of effect on the Company's finances and business:None.
11.If the director has invested in the mainland China area enterprise, the
   monetary amount of the director's investment and the director's
   shareholding ratio:None.
12.Any other matters that need to be specified:
The BOD is authorized to exercise the rights of
the shareholders' meeting pursuant to Article 15
of the Financial Holding Company Act.